Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastoma
Kimberley M. Hanssen(The University of Sydney), Michelle Haber(Cancer Clinic)
Cited by 1
Related Papers
Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma
|Clinical Cancer Research|2021|31
Gaq signaling is required for the maintenance of MLL-AF9-induced acute myeloid leukemia
|Leukemia|2016|10
24 (PB012): Runx1t1 is an epigenetic regulator essential for MYCN-driven neuroblastoma tumorigenesis
|European Journal of Cancer|2024|0